SpringWorks Therapeutics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
2,426
Transactions
5,727
2024 Total
$5.3M
Payment Breakdown by Category
Research$3.9M (74.1%)
Consulting$310,945 (5.9%)
Food & Beverage$118,638 (2.3%)
Travel$61,901 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.9M | 1,310 | 74.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $797,466 | 152 | 15.2% |
| Consulting Fee | $310,945 | 101 | 5.9% |
| Food and Beverage | $118,638 | 3,835 | 2.3% |
| Grant | $75,500 | 14 | 1.4% |
| Travel and Lodging | $61,901 | 315 | 1.2% |
Payments by Type
Research
$3.9M
1,310 transactions
General
$1.4M
4,417 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| MEK-NF-201 | $1.3M | 0 | 209 |
| NIR-DT-301 | $640,824 | 0 | 107 |
| NIR-OGT-201 | $578,667 | 0 | 607 |
| MEKRAF-AST-101 | $520,520 | 0 | 300 |
| TEAD-AST-101 | $313,065 | 0 | 75 |
| A PHASE II STUDY OF CRYOABLATION PLUS NIROGACESTAT FOR DESMOID TUMOR | $214,983 | 0 | 5 |
| PHASE 1B/2A, OPEN -LABEL PLATFORM STUDY TO EVALUATE MIRDAMETINIB AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTICANCER AGENTS IN PATIENTS WITH ADVANCED SOLID CANCERS HAROBIRING MAPK-ACTIVATING TUMORS | $49,602 | 0 | 1 |
| A SAFETY,PHARMACOKINETIC AND EFFICACY STUDY OF A ?-SECRETASE INHIBITOR, NIROGACESTAT IN CHILDREN AND ADOLESCENTS WITH PROGRESSIVE, SURGICALLY UNRESECTABLE DESMOID TUMORS | $11,740 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Noah Federman, M.d, M.D | Pediatric Hematology-Oncology | Los Angeles, CA | $89,991 | $0 |
| Pedro Hermida De Viveiros, Md, MD | Hematology & Oncology | Chicago, IL | $59,245 | $0 |
| Dipak Ramkumar, M.d, M.D | Surgical Oncology | Phoenix, AZ | $37,377 | $0 |
| Sajeve Thomas, Md, MD | Hematology & Oncology | Orlando, FL | $26,884 | $0 |
| Dr. Kamlesh Sankhala, M.d, M.D | Medical Oncology | Beverly Hills, CA | $20,638 | $0 |
| Dr. Seth Pollack, Md, MD | Hematology & Oncology | Chicago, IL | $19,989 | $0 |
| Mr. Bassan Allan | Surgical Oncology | Fort Myers, FL | $17,322 | $0 |
| Dr. Amy Armstrong, Md, MD | Pediatrics | Saint Louis, MO | $15,985 | $0 |
| Gina D'amato, Md, MD | Internal Medicine | Atlanta, GA | $15,703 | $0 |
| Mark Agulnik, Md, MD | Medical Oncology | Los Angeles, CA | $14,557 | $0 |
| Dr. Maciej Mrugala, Md Phd Mph, MD PHD MPH | Medical Oncology | Scottsdale, AZ | $14,424 | $0 |
| Phioanh Nghiemphu, Md, MD | Neurology | Los Angeles, CA | $11,625 | $0 |
| Dan Blazer, M.d, M.D | Surgical Oncology | Durham, NC | $11,436 | $0 |
| Robert Randall, Md, MD | Orthopaedic Surgery | Sacramento, CA | $11,414 | $0 |
| Mr. Matthew Dicaprio, Md, MD | Orthopaedic Surgery | Schenectady, NY | $11,240 | $0 |
| Dr. James Hu, M.d, M.D | Medical Oncology | Los Angeles, CA | $11,014 | $0 |
| Dr. Nicole Brossier, Md, MD | Pediatrics | Saint Louis, MO | $10,823 | $0 |
| Dr. Tony Philip, Md, MD | Hematology & Oncology | New Hyde Park, NY | $10,501 | $0 |
| Jeffrey Wayne, Md, MD | Surgical Oncology | Chicago, IL | $10,287 | $0 |
| Dr. Angela Hirbe, Md, MD | Medical Oncology | Saint Louis, MO | $9,999 | $0 |
| Dr. Anna Piotrowski, M. D, M. D | Student in an Organized Health Care Education/Training Program | New York, NY | $9,928 | $0 |
| Justin Jordan, Md, Mph, MD, MPH | Neurology | Dallas, TX | $8,560 | $0 |
| Maura Di Nicola, Md, MD | Uveitis and Ocular Inflammatory Disease | Miami, FL | $8,500 | $0 |
| Dr. Arun Singh, M.d, M.D | Hematology & Oncology | Santa Monica, CA | $8,418 | $0 |
| Dr. Camilo Molina, Md, MD | Neurological Surgery | Saint Louis, MO | $8,000 | $0 |
About SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. has made $5.3M in payments to 2,426 healthcare providers, recorded across 5,727 transactions in the CMS Open Payments database. In 2024, the company paid $5.3M. The top product by payment volume is OGSIVEO ($493,656).
Payments were distributed across 79 medical specialties. The top specialty by payment amount is Hematology & Oncology ($199,702 to 763 doctors).
Payment categories include: Food & Beverage ($118,638), Consulting ($310,945), Research ($3.9M), Travel & Lodging ($61,901).
SpringWorks Therapeutics, Inc. is associated with 1 products in the CMS Open Payments database.